Results 21 to 30 of about 8,311 (216)

Lymphoplasmacytic lymphoma infiltrating both lacrimal glands in a patient with Waldenström's macroglobulinemia

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: To describe a case of Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma with infiltration of both lacrimal glands. Observations: A 63-year-old male with Waldenström's macroglobulinemia was referred to the ophthalmological clinic due to ...
Andreas Vangsted   +3 more
doaj   +1 more source

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports

open access: yesJournal of Medical Case Reports, 2020
Background Immunoglobulin M multiple myeloma and Waldenström macroglobulinemia are two different hematological diseases with the common finding of an immunoglobulin M monoclonal gammopathy of unknown significance. However, clinical characteristics of the
Simona Elba   +15 more
doaj   +1 more source

Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature

open access: yesCase Reports in Oncological Medicine, 2014
Background. Recent literature has associated hepatitis C virus with the development of non-Hodgkin lymphoma. Hepatitis C virus infection appears to promote lymphoproliferation, providing a plausible mechanism for a causative association; however, despite
Ryan Nipp   +3 more
doaj   +1 more source

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

open access: yesHemaSphere, 2020
. In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients ...
Dipti Talaulikar   +17 more
doaj   +1 more source

Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: A diagnostic and therapeutic challenge

open access: yesClinical Case Reports, 2022
We report a case based on simultaneous occurrence of Waldenström macroglobulinemia, myeloma and amyloidosis as a collision neoplasm. The strangeness and severity of the case presented a diagnostic and therapeutic challenge, which required individualised ...
Candela Ceballos   +7 more
doaj   +1 more source

Familial Waldenstrom's macroglobulinemia [PDF]

open access: yesSeminars in Oncology, 2003
The etiology of Waldenstrom's macroglobulinemia (WM) is unknown. A possible role for genetic factors has been suggested by reports of familial clustering of WM. However, it is not yet possible to define the proportion of all WM that occurs in the familial setting.
openaire   +3 more sources

Cutaneous Macroglobulinosis Presenting as Serpiginous Purpura, a Case Report and Literature Review

open access: yesClinical, Cosmetic and Investigational Dermatology, 2021
Siriorn Sukanjanapong,1 Kumutnart Chanprapaph,1 Suthinee Rutnin,1 Paisan Boonsakan,2 Sulada Pukiat3 1Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Department of Pathology, Faculty of Medicine,
Sukanjanapong S   +4 more
doaj  

Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia

open access: yesHaematologica, 2018
We here describe a novel method for MYD88L265P mutation detection and minimal residual disease monitoring in Waldenström macroglobulinemia, by droplet digital polymerase chain reaction, in bone marrow and peripheral blood cells, as well as in circulating
Daniela Drandi   +20 more
doaj   +1 more source

Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide

open access: yesJournal of Clinical Oncology, 2001
PURPOSE: We performed a prospective phase II study to assess the activity of thalidomide in patients with Waldenstrom’s macroglobulinemia (WM). PATIENTS AND METHODS: Twenty patients with WM were treated with thalidomide at a starting dose of 200 mg daily with dose escalation in 200-mg increments every 14 days as tolerated to a maximum of 600 mg.
Dimopoulos, Meletios A   +8 more
openaire   +4 more sources

BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom’s Macroglobulinemia [PDF]

open access: yes, 2023
High-dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) is an option to consolidate remission in Waldenstrom’s macroglobulinemia (WM), particularly in selected younger patients with chemosensitive disease. BEAM, consisting of
Beck, Philipp   +13 more
core   +2 more sources

Home - About - Disclaimer - Privacy